Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
Personalised cancer medicine using the human protein atlas and affibodies
Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden
Personalised cancer medicine using the human protein atlas and affibodies ( Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden )
26 Jun 2014
ecancermedicalscience editor's choice for June 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for June 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
24 Jun 2014
Summary of breaking prostate news from ASCO 2014
Prof Eleni Efstathiou and Prof Gordon McVie
Summary of breaking prostate news from ASCO 2014 ( Prof Eleni Efstathiou and Prof Gordon McVie )
2 Jun 2014
Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic...
Prof Thomas Powles - Barts Health, London, UK
Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic urothelial bladder cancer ( Prof Thomas Powles - Barts Health, London, UK )
2 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
Addition of docetaxel to initial hormone therapy substantially improves...
Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA
Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA )
2 Jun 2014
Addition of docetaxel to initial hormone therapy substantially improves...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2014
ASCO 2014: Advances in prostate cancer discussion
Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki
ASCO 2014: Advances in prostate cancer discussion ( Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki )
1 Jun 2014
Addition of docetaxel to initial hormone therapy substantially improves...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2014
Medyczne nowości w raku gruczołu krokowego
Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland
Medyczne nowości w raku gruczołu krokowego ( Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland )
1 Jun 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014
Lecture: PSA Screening - Where East meets West
Dr Liping Xie - Zhejian Medical Univeristy, Zhejian, China
Lecture: PSA Screening - Where East meets West ( Dr Liping Xie - Zhejian Medical Univeristy, Zhejian, China )
12 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation